Literature DB >> 8149964

Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments.

C A Kettleborough1, K H Ansell, R W Allen, E Rosell-Vives, D H Güssow, M M Bendig.   

Abstract

Enhanced expression of epidermal growth factor receptor (EGFR) occurs on a variety of malignant tissues thus making anti-EGFR antibodies possible agents for the diagnosis and therapy of human tumors. Standard hybridoma technology has been used successfully to isolate anti-EGFR antibodies from immunized mice and rats. This report demonstrates that phage-antibody libraries are an alternative, and more versatile, method for isolating antibodies from immunized mice. Anti-EGFR antibodies were isolated from phage-antibody libraries constructed not only from the spleen of an immunized mouse but also from the draining lymph node of an immunized mouse and from in vitro immunized mouse cells. Two of the single-chain Fv isolated from the phage-antibody libraries were engineered to create partially humanized whole antibody molecules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149964     DOI: 10.1002/eji.1830240426

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

Review 1.  Recombinant antibodies for the diagnosis and treatment of cancer.

Authors:  Jürgen Krauss
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

Review 2.  Demystified...recombinant antibodies.

Authors:  K A Smith; P N Nelson; P Warren; S J Astley; P G Murray; J Greenman
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

3.  Molecular cloning, expression, and characterization of a functional single-chain Fv antibody to the mycotoxin zearalenone.

Authors:  Q Yuan; J R Clarke; H R Zhou; J E Linz; J J Pestka; L P Hart
Journal:  Appl Environ Microbiol       Date:  1997-01       Impact factor: 4.792

4.  Assessment of antibody library diversity through next generation sequencing and technical error compensation.

Authors:  Marco Fantini; Luca Pandolfini; Simonetta Lisi; Michele Chirichella; Ivan Arisi; Marco Terrigno; Martina Goracci; Federico Cremisi; Antonino Cattaneo
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

Review 5.  Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale.

Authors:  Jody D Berry
Journal:  Vet J       Date:  2005-09       Impact factor: 2.688

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.